Suppr超能文献

临床研究荟萃分析中纳入非随机研究与随机对照试验:干预效果估计的元流行病学研究

Integration of non-randomized studies with randomized controlled trials in meta-analyses of clinical studies: a meta-epidemiological study on effect estimation of interventions.

作者信息

Mei Fan, Yao Minghong, Wang Yuning, Huan Jiayidaer, Ma Yu, Li Guowei, Zou Kang, Li Ling, Sun Xin

机构信息

Institute of Integrated Traditional Chinese and Western Medicine, Chinese Evidence-Based Medicine Center, Cochrane China and MAGIC China Center, West China Hospital, Sichuan University, Chengdu, China.

NMPA Key Laboratory for Real World Data Research and Evaluation in Hainan, Chengdu, China.

出版信息

BMC Med. 2024 Dec 2;22(1):571. doi: 10.1186/s12916-024-03778-1.

Abstract

BACKGROUNDS

Syntheses of non-randomized studies of interventions (NRSIs) and randomized controlled trials (RCTs) are increasingly used in decision-making. This study aimed to summarize when NRSIs are included in evidence syntheses of RCTs, with a particular focus on the methodological issues associated with combining NRSIs and RCTs.

METHODS

We searched PubMed to identify clinical systematic reviews published between 9 December 2017 and 9 December 2022, randomly sampling reviews in a 1:1 ratio of Core and non-Core clinical journals. We included systematic reviews with RCTs and NRSIs for the same clinical question. Clinical scenarios for considering the inclusion of NRSIs in eligible studies were classified. We extracted the methodological characteristics of the included studies, assessed the concordance of estimates between RCTs and NRSIs, calculated the ratio of the relative effect estimate from NRSIs to that from RCTs, and evaluated the impact on the estimates of pooled estimates when NRSIs are included.

RESULTS

Two hundred twenty systematic reviews were included in the analysis. The clinical scenarios for including NRSIs were grouped into four main justifications: adverse outcomes (n = 140, 63.6%), long-term outcomes (n = 36, 16.4%), the applicability of RCT results to broader populations (n = 11, 5.0%), and other (n = 33, 15.0%). When conducting a meta-analysis, none of these reviews assessed the compatibility of the different types of evidence prior, 203 (92.3%) combined estimates from RCTs and NRSIs in the same meta-analysis. Of the 203 studies, 169 (76.8%) used crude estimates of NRSIs, and 28 (13.8%) combined RCTs and multiple types of NRSIs. Seventy-seven studies (35.5%) showed "qualitative disagree" between estimates from RCTs and NRSIs, and 101 studies (46.5%) found "important difference". The integration of NRSIs changed the qualitative direction of estimates from RCTs in 72 out of 200 studies (36.0%).

CONCLUSIONS

Systematic reviews typically include NRSIs in the context of assessing adverse or long-term outcomes. The inclusion of NRSIs in a meta-analysis of RCTs has a substantial impact on effect estimates, but discrepancies between RCTs and NRSIs are often ignored. Our proposed recommendations will help researchers to consider carefully when and how to synthesis evidence from RCTs and NRSIs.

摘要

背景

干预性非随机研究(NRSIs)和随机对照试验(RCTs)的综合分析越来越多地用于决策制定。本研究旨在总结NRSIs何时被纳入RCTs的证据综合分析中,特别关注与合并NRSIs和RCTs相关的方法学问题。

方法

我们检索了PubMed,以确定2017年12月9日至2022年12月9日期间发表的临床系统评价,按照核心和非核心临床期刊1:1的比例随机抽取综述。我们纳入了针对同一临床问题的包含RCTs和NRSIs的系统评价。对在符合条件的研究中考虑纳入NRSIs的临床场景进行了分类。我们提取了纳入研究的方法学特征,评估了RCTs和NRSIs之间估计值的一致性,计算了NRSIs与RCTs相对效应估计值的比值,并评估了纳入NRSIs时对合并估计值的影响。

结果

220篇系统评价纳入了分析。纳入NRSIs的临床场景主要分为四类理由:不良结局(n = 140,63.6%)、长期结局(n = 36,16.4%)、RCT结果对更广泛人群的适用性(n = 11,5.0%)以及其他(n = 33,15.0%)。在进行荟萃分析时,这些综述均未事先评估不同类型证据的兼容性,203篇(92.3%)在同一荟萃分析中合并了RCTs和NRSIs的估计值。在这203项研究中,169项(76.8%)使用了NRSIs的粗略估计值,28项(13.8%)合并了RCTs和多种类型的NRSIs。77项研究(35.5%)显示RCTs和NRSIs的估计值之间存在“定性不一致”,101项研究(46.5%)发现存在“重要差异”。在200项研究中,有72项(36.0%)纳入NRSIs后改变了RCTs估计值的定性方向。

结论

系统评价通常在评估不良或长期结局时纳入NRSIs。在RCTs的荟萃分析中纳入NRSIs对效应估计有重大影响,但RCTs和NRSIs之间的差异常常被忽视。我们提出的建议将帮助研究人员仔细考虑何时以及如何综合RCTs和NRSIs的证据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7274/11613474/57cbbc9f6e6a/12916_2024_3778_Fig1_HTML.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验